Back

Sudden death risk assessment in hypertrophic cardiomyopathy should include myocardial fibrosis imaging - discussion

1 September 2024 (11:30 - 12:00)
Organised by: Logo
Congress Presentation Part of: Great Debate: assessing the risk of sudden death in hypertrophic cardiomyopathy should include myocardial fibrosis imaging Hypertrophic Cardiomyopathy ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

2 More presentations in this session

Presentation thumbnail
Sudden death risk assessment in hypertrophic cardiomyopathy should include myocardial fibrosis imaging: pro
Doctor C. Kramer (Charlottesville, US)
Slides Video
Presentation thumbnail
Sudden death risk assessment in hypertrophic cardiomyopathy should include myocardial fibrosis imaging: con
Doctor A. Kammerlander (Vienna, AT)
Slides Video

Access the full session

Session thumbnail
Great Debate: assessing the risk of sudden death in hypertrophic cardiomyopathy should include myocardial fibrosis imaging
Video

The Event

Event poster

ESC Congress 2024

1 September 2024 11:30 CET
You may be interested in
thumbnail
Congress Session
Great Debate: assessing the risk of sudden death in hypertrophic cardiomyopathy should include myocardial fibrosis imaging
thumbnail
Congress Presentation
Myocardial scar imaging and risk of sudden cardiac death - ready for prime time? - discussion
thumbnail
Congress Presentation
State-of-the-art lecture on risk stratification of sudden cardiac death in cardiomyopathies: can we predict the unpredictable?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources